REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Beijing Biostar Pharmaceuticals Co. Ltd. (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Beijing Biostar Pharmaceuticals Co. Ltd. Profile Updated: March 31, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Beijing Biostar Pharmaceuticals Co Ltd is engaged in the research, development, production and sales of innovative drugs. The company's main products include Utidelone Injection, Utidelone Capsule, Utidelone Nanoformulation, Utidelone Antibody Drug Conjugate (ADC), BG22, BG18 and BG44. The company was established in 2002 and is headquartered in Beijing city, China.

Headquarters
1202, Tower B, Yicheng Fortune Center, Beijing Economic-Technological Development Area
Beijing; Beijing;

Contact Details: Purchase the Beijing Biostar Pharmaceuticals Co. Ltd. report to view the information.

Website: http://www.biostar-pharm.com

Basic Information
Outstanding Shares:
Purchase the Beijing Biostar Pharmaceuticals Co. Ltd. report to view the information.
Financial Auditors:
Purchase the Beijing Biostar Pharmaceuticals Co. Ltd. report to view the information.
Incorporation Date:
2002
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Executive Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
29.47%
Purchase this report to view the information.
8.41%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
Biostar Pharma, Inc. (United States)
100%
Chengdu Biostar Pharmaceutical Co., Ltd.
100%
Company Performance
Created with Highstock 1.3.7Chart context menu2022Y2023Y
Net sales revenue
Net Profit (Loss) for the Period
Net Profit Margin
Financial values in the chart are available after Beijing Biostar Pharmaceuticals Co. Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
103.03%▲
Total operating revenue
42.04%▲
Operating profit (EBIT)
-12.82%▼
EBITDA
-13.42%▼
Net Profit (Loss) for the Period
-18.15%▼
Total assets
-16.62%▼
Total equity
-16.68%▼
Operating Profit Margin (ROS)
261.33%▲
Net Profit Margin
204.46%▲
Return on Equity (ROE)
-7.73%▼
Debt to Equity Ratio
-0.1%▼
Quick Ratio
-1.1%▼
Cash Ratio
-0.29%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo